4.3 Article

Confocal laser-scanning capillaroscopy: a novel approach to the analysis of skin capillaries in vivo

期刊

SKIN RESEARCH AND TECHNOLOGY
卷 15, 期 4, 页码 476-481

出版社

WILEY
DOI: 10.1111/j.1600-0846.2009.00393.x

关键词

confocal microscopy; capillaroscopy; imageJ; capillary

资金

  1. Ludwig-Maximilian University

向作者/读者索取更多资源

Background New techniques for diagnostics and therapy in dermatology are becoming increasingly non-invasive, among which confocal laser-scanning microscopy (CLSM) is the most prevalent. It allows visualization of cellular structures of the skin up to a depth of 300 mu m in vivo. Until now, most studies have been conducted on pathologically altered skin, mostly oncologic lesions. We now present a detailed analysis of capillaries located in the upper dermal papillae. Methods Multiple measurements were performed on the dorsal and ventral surface of the right forearm of 30 healthy volunteers (22-88 years) under standard conditions (room temperature, body position, time of day). Images were obtained with the Vivascope 1500 (Lucid) under standard settings and analyzed using the freeware ImageJ with a customwritten macro plugin. The following parameters of the capillaries in vivo were measured: area, perimeter, circularity and maximum diameter. Results Statistical analysis showed that all four parameters were constant within a narrow range, regardless of the body site, sex and age. In this physiological study, we can clearly demonstrate that by confocal laser-scanning capillaroscopy (CLSC), it is possible to visualize and measure skin capillaries at the extremities in a reproducible manner. Conclusion This new approach offers a considerable advantage compared with nailfold capillaroscopy, which can only be performed at the proximal nail segment, and over histological analysis, which can be hampered by fixation artifacts resulting in altered size and shape of the vessels to be analyzed. CLSC could allow for precise analysis of in vivo skin vasculature in systemic and proliferative diseases of the skin.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Dermatology

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma

M. Arenbergerova, A. Fialova, S. Gkalpakiotis, R. Kodet, T. Jancarkova, M. Novotna, A. Hess, I. Puzanov, P. Arenberger

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)

Letter Dermatology

Severe diclofenac photoallergy in a patient treated with vemurafenib

M. Arenbergerova, A. Fialova, P. Arenberger, J. Ettler, A. Srp, J. Dvorak, S. Gkalpakiotis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)

Article Dermatology

Quantitative changes of melanoma-associated antigens as a biomarker for targeted therapy response

Petr Arenberger, Alena Fialova, Spyridon Gkalpakiotis, Andrea Pavlikova, Monika Arenbergerova

EXPERIMENTAL DERMATOLOGY (2016)

Article Dermatology

Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study

Spyridon Gkalpakiotis, Monika Arenbergerova, Petra Gkalpakioti, Jana Potockova, Petr Arenberger, Pavel Kraml

JOURNAL OF DERMATOLOGY (2017)

Letter Dermatology

Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure

M. Arenbergerova, I. Mrazova, J. Horazdovsky, E. Sticova, A. Fialova, P. Arenberger

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Dermatology

Melanoma antigens are biomarkers for ipilimumab response

P. Arenberger, A. Fialova, S. Gkalpakiotis, A. Pavlikova, I. Puzanov, M. Arenbergerova

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Oncology

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

N. Basset-Seguin, A. Hauschild, R. Kunstfeld, J. Grob, B. Dreno, L. Mortier, P. A. Ascierto, L. Licitra, C. Dutriaux, L. Thomas, N. Meyer, B. Guillot, R. Dummer, P. Arenberger, K. Fife, A. Raimundo, E. Dika, N. Dimier, A. Fittipaldo, I. Xynos, J. Hansson

EUROPEAN JOURNAL OF CANCER (2017)

Article Dermatology

Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries

Martina Kojanova, Jorga Fialova, Petra Cetkovska, Spyridon Gkalpakiotis, Jitka Jircikova, Tomas Dolezal, Petr Arenberger

INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)

Review Dermatology

New and current preventive treatment options in actinic keratosis

P. Arenberger, M. Arenbergerova

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Medicine, General & Internal

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

J. Weber, M. Mandala, M. Del Vecchio, H. J. Gogas, A. M. Arance, C. L. Cowey, S. Dalle, M. Schenker, V. Chiarion-Sileni, I. Marquez-Rodas, J-J. Grob, M. O. Butler, M. R. Middleton, M. Maio, V. Atkinson, P. Queirolo, R. Gonzalez, R. R. Kudchadkar, M. Smylie, N. Meyer, L. Mortier, M. B. Atkins, G. V. Long, S. Bhatia, C. Lebbe, P. Rutkowski, K. Yokota, N. Yamazaki, T. M. Kim, V. de Pril, J. Sabater, A. Qureshi, J. Larkin, P. A. Ascierto

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Letter Dermatology

Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis

S. Gkalpakiotis, P. Arenberger, P. Skalicka, M. Arenbergerova

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Letter Dermatology

Alopecia barbae severity score: a novel scoring system to estimate the extent of beard loss and success of treatment

A. J. Stefanis, P. Arenberger, M. Arenbergerova, S. Gkalpakiotis

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Dermatology

Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic

Alzbeta Smetanova, Emanuel Marques, Martina Kojanova, Petr Arenberger, Daniela Strosova, Jorga Fialova, Monika Arenbergerova

Summary: This multicenter observational study evaluated the effectiveness, safety, and drug survival of adalimumab in patients with moderate-to-severe hidradenitis suppurativa. The results showed that adalimumab demonstrated sustained and rapid effects in improving the condition, reducing inflammatory lesions, and enhancing patients' quality of life during the 48-month treatment period, with no unexpected risk signals observed.

DERMATOLOGIC THERAPY (2023)

Letter Dermatology

Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma

Spyridon Gkalpakiotis, Petr Arenberger, Marketa Fridman, Monika Arenbergerova

DERMATOLOGIC THERAPY (2017)

Article Dermatology

The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis

C. E. M. Griffiths, D. Thaci, S. Gerdes, P. Arenberger, G. Pulka, K. Kingo, J. Weglowska, N. Hattebuhr, J. Poetzl, H. Woehling, G. Wuerth, M. Afonso

BRITISH JOURNAL OF DERMATOLOGY (2017)

暂无数据